Smith & Nephew (Smith & Nephew) Net Change in Cash : $-44 Mil (TTM As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Smith & Nephew's Net Change in Cash for the six months ended in Dec. 2023 was $117 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $-44 Mil.

Smith & Nephew Net Change in Cash Historical Data

The historical data trend for Smith & Nephew's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Net Change in Cash Chart

Smith & Nephew Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-76.00

1,494.00

-466.00

-941.00

-44.00

Smith & Nephew Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															-94.00	-773.00	-168.00	-161.00	117.00

Smith & Nephew Net Change in Cash Calculation

Smith & Nephew's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	608	+	-448	+	-200	+	-4
	=	-44

Smith & Nephew's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 495 + -266 + -114 + 2

= 117

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smith & Nephew Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Smith & Nephew's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Smith & Nephew (Smith & Nephew) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Net Change in Cash

Comparable Companies

LSE:MXCT LSE:NIOX LSE:EKF LSE:CREO LSE:IUG LSE:BELL LSE:IHC LSE:POLX LSE:MHC LSE:RUA TSE:5212 ABT SYK MDT BSX EW DXCM SZSE:300760 ZBH ALGN

Traded in Other Exchanges

SNNUF:USA SNl:UK SN.:UK NPW1:Germany NPWA:Germany NPW1:Germany S1NN34:Brazil

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus

Smith+Nephew announces first surgery for its JOURNEY� II Medial Dished System for total knee arthroplasty
By PRNewswire PRNewswire • 02-10-2022

Smith+Nephew expands procedural innovation with introduction of JOURNEY� II ROX� Total Knee Solution
By PRNewswire PRNewswire • 11-01-2022

Smith+Nephew announces first robotic-assisted surgery using its LEGION� CONCELOC� Cementless Total Knee System
By PRNewswire PRNewswire • 06-30-2022

Smith+Nephew announces first total hip replacement cases on its CORI� Surgical System using RI.HIP MODELER and RI.HIP NAVIGATION
By PRNewswire PRNewswire • 06-08-2022

Smith+Nephew receives Innovative Technology designation from Vizient for LEAF� Patient Monitoring System
By PRNewswire PRNewswire • 01-30-2023

New evidence demonstrates Smith+Nephew's COBLATION� Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques
By PRNewswire PRNewswire • 03-23-2023

SMITH+NEPHEW SHARES NEW RESEARCH THAT ESTIMATES 3.5 BILLION HOURS OF NURSE TIME COULD BE RELEASED BY 2030 THROUGH SHARED WOUND CARE AND USE OF LONG-WEAR ADVANCED FOAM DRESSINGS
By PRNewswire PRNewswire • 06-24-2022

Smith+Nephew's PICO� 7 and PICO 14 Negative Pressure Wound Therapy Systems are the first systems indicated to aid in reducing the incidence of both deep and superficial incisional surgical site infections and dehiscence
By PRNewswire PRNewswire • 01-24-2022

Smith+Nephew's OXINIUM� Technology Tour of Change touches down at the Pro Football Hall of Fame during enshrinement weekend
By PRNewswire PRNewswire • 08-04-2022

Smith & Nephew PLC: An In-depth Analysis of its Dividend Performance
By GuruFocus Research • 10-05-2023